Addiction

·

News

Phase 2 Trial Approved for Psilocybin to Treat Meth Addiction

Phase 2 Trial Approved for Psilocybin to Treat Meth Addiction

Psilocybin mushrooms

What they found

Health Canada and the FDA authorized Filament Health's Phase 2 trial of a psilocybin-based treatment for methamphetamine addiction.

Health Canada and the FDA authorized Filament Health's Phase 2 trial of a psilocybin-based treatment for methamphetamine addiction.

How solid is it?

n/a

n/a

Not a study

Not a study

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin (PEX010)

psilocybin (PEX010)

Published in

Filament Health

Filament Health

Covered in Shroom Scan

Section

PSILOCYBIN & LEGISLATION

PSILOCYBIN & LEGISLATION

As it ran in Shroom Scan

International Approval

International Approval

Health Canada and the U.S. FDA have authorized Filament Health for Phase 2 clinical testing of its psilocybin-based treatment for methamphetamine addiction.

Health Canada and the U.S. FDA have authorized Filament Health for Phase 2 clinical testing of its psilocybin-based treatment for methamphetamine addiction.

Psilocybin for Addiction, Plastic-Eating Fungus, and World's Largest Wildlife Bridge

Read the original study ↗

Get Shroom Scan

Next study

Canada's Optimi Health Cleared to Export Psilocybin to Australia ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →